Mr. Hani Zabaneh reports

ADAPTOGENICS HEALTH CORP. ANNOUNCES SHARE CONSOLIDATION

Adaptogenics Health Corp. intends to consolidate the common shares of the company on a four-to-one basis. The company has 16,397,701 common shares outstanding, and, if completed, the proposed consolidation would reduce the issued and outstanding common shares to approximately 4,099,425 common shares. Subject to review and acceptance by the Canadian Securities Exchange, the consolidation is expected to become effective at market open on or about July 15, 2026.

Pursuant to the provisions of the Business Corporations Act (British Columbia) and the articles of the company and in accordance with the policies of the Canadian Securities Exchange, the consolidation was approved by way of resolutions passed by the board of directors of the company.

The exercise or conversion price of any outstanding warrants and options, and the number of common shares issuable thereunder, will also be proportionately adjusted upon the completion of the consolidation. No fractional shares will be issued as a result of the consolidation. All fractional common shares resulting from the consolidation that are equal to or greater than one-half will be rounded up to the next whole number. Fractional common shares resulting from the consolidation that are less than one-half will be cancelled without any repayment of capital or other compensation.

The company's new Cusip number will be 00654R208, and the new ISIN will be CA 00654R2081. The company's name and trading symbol will remain unchanged.

Registered shareholders who hold physical common share certificates will receive a letter of transmittal requesting that they forward preconsolidation share certificates to the company's transfer agent, Odyssey Trust Company, in exchange for new common share certificates representing common shares on a postconsolidation basis. Shareholders who hold their common shares through a broker or other intermediary and do not have common shares registered in their own name will not be required to complete a letter of transmittal.

About Adaptogenics Health Corp.

Adaptogenics is a Canadian-based nutraceutical company that has focused on the formulation and distribution of functional mushroom products and nutritional supplement alternatives. The company is committed to its mission of improving and empowering human health and well-being.

We seek Safe Harbor.